Europe Antibody Discovery Market Forecast to 2030

At 6.2% CAGR, Europe Antibody Discovery Market is Speculated to be Worth US$ 13,29,481.60 Million by 2030, says The Research Team

According toThe Research Team’ research, the Europe antibody discovery market was valued at US$ 8,24,441.11 million in 2022 and is expected to reach US$ 13,29,481.60 million by 2030, registering a CAGR of 6.2% from 2022 to 2030. Developments for custom antibodies and proliferation of biotechnology industry in developing regions are among the critical factors attributed to drive the Europe antibody discovery market growth.

The remarkable precision of antibodies in identifying antigens makes them invaluable tools for scientists and clinicians. In modern biotechnology, antibodies are required in numerous processes, from basic research to innovative medical evaluations. The development of therapeutic antibodies has opened new avenues in treating various diseases, demonstrating the transformative ability of these particles. Antibodies are also crucial in antibody-based diagnostics as they provide accurate and reliable approaches to disease identification. Growing support from governments, rising public-private partnerships, continuously changing disease profiles, and increasing funding activities are widely enhancing the performance of biotechnology industries.

Heavy investments encourage the adoption of advanced technologies in the healthcare sector. Therefore, the ongoing proliferation of biotechnology industries in developing regions is expected to create opportunities for the antibody discovery market in the coming years.

On the contrary, high cost of production hurdles the growth of Europe antibody discovery market.

Based on antibody type, the Europe antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held 83.5% market share in 2022, amassing US$ 688.56 billion. It is projected to garner US$ 1,134.84 billion by 2030 to register 6.4% CAGR during 2022-2030.

In terms of nature, the Europe antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held 56.1% share of Europe antibody discovery market in 2022, amassing US$ 462.91 billion. It is anticipated to garner US$ 772.42 billion by 2030 to expand at 6.6% CAGR during 2022-2030.

By services, the Europe antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held 35.9% share of Europe antibody discovery market in 2022, amassing US$ 296.18 billion. It is projected to garner US$ 501.92 billion by 2030 to expand at 6.8% CAGR from 2022 to 2030.

Based on end user, the Europe antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held 54.4% share of Europe antibody discovery market in 2022, amassing US$ 448.86 billion. It is predicted to garner US$ 754.65 billion by 2030 to expand at 6.7% CAGR between 2022 and 2030.

Based on country, the Europe antibody discovery market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 28.7% share of Europe antibody discovery market in 2022. It was assessed at US$ 236.61 billion in 2022 and is likely to hit US$ 399.64 billion by 2030, registering a CAGR of 6.8% during 2022-2030.

Key players operating in the Europe antibody discovery market are Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd, among others.

In January 2024, Biocytogen Pharmaceuticals Co Ltd launched a new sub-brand, RenBiologics, to represent the company’s antibody discovery business division. RenBiologics business will cover out-licensing/co-development of the company’s extensive library of fully human antibodies, as well as licensing of RenMice, the company’s fully human antibody/TCR discovery platforms.

In August 2023, Twist Bioscience Corp announced a drug discovery agreement with Ono Pharmaceutical Co Ltd to discover and develop novel antibodies for the treatment of autoimmune diseases.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibody Discovery Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market – Europe Market Analysis
5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. Europe Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Antibody Discovery Market – Country Analysis
10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Europe: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK
10.1.1.1.1 Overview
10.1.1.1.2 UK: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Europe
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. UK: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. UK: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. UK: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. UK: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Germany: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Germany: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Germany: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Germany: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. France: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. France: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. France: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. France: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Italy: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 16. Italy: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 17. Italy: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 18. Italy: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 19. Spain: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 20. Spain: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 21. Spain: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 22. Spain: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 23. Rest of Europe: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 24. Rest of Europe: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 25. Rest of Europe: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 26. Rest of Europe: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market

LIST OF FIGURES

Figure 1. Europe Antibody Discovery Market Segmentation, by Country
Figure 2. Europe Antibody Discovery Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 5. Europe Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 10. Human and Humanized: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 14. Phage Display: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. UK: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. Germany: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Italy: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Spain: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Europe: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Antibody Discovery Market